Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nobile-Orazio, E.
Right arrow Articles by Rowland, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nobile-Orazio, E.
Right arrow Articles by Rowland, L. P.
NEUROLOGY 1984;34:218
© 1984 American Academy of Neurology

Neuropathy and anti-MAG antibodies without detectable serum M-protein

Eduardo Nobile-Orazio, Norman Latov, Arthur P. Hays, Masami Takatsu, Gary M. Abrams, William H. Sherman, James R. Miller, Mary-Jo Messito, Toyokazu Saito, Albert Tahmoush, Robert E. Lovelace and Lewis P. Rowland

From the Department of Neurology (Drs. Nobile-Orazio, Latov, Abrams, Miller, Messito, Saito, Tahmoush, Lovelace, and Rowland) Neuropathology (Drs. Hays and Takatsu), and Medicine (Dr. Sherman), Columbia University College of Physicians and Surgeons, New York.

Anti-MAG IgM antibodies were detected by ELISA in a patient with slowly progressive peripheral neuropathy. Serum IgM content was normal, and no M-protein was detected by serum protein electrophoresis, immunoelectrophoresis, or immunostaining. By immunoblot analysis, the anti-MAG antibodies were IgMk; they reacted with human and bovine MAG but not with mouse MAG. The data suggest that there was an anti-MAG IgM M-protein in concentration too low to be detected by conventional techniques. Tests for anti-MAG antibodies should be done in patients with slowly progressive neuropathy of unknown etiology, even in the absence of detectable serum M-protein.

Address correspondence and reprint requests to Dr. Latov, Department of Neurology, Columbia University, College of Physicians and Surgeons, Black Bldg. Rm. 3.323, 630 West 168th Street, New York, NY 10032.

Supported by grants Nos. NS18016 and NS00659 from the NINCDS and by a grant from the Muscular Dystrophy Association. Dr. Nobile-Orazio is a visiting fellow from the Institute of Clinical Neurology, University of Milan, Italy, and is the recipient of the "De Visart" Award. Dr. M. Takatsu is a visiting fellow from Tokyo University, Japan, and is the recipient of a fellowship from the Muscular Dystrophy Association. Dr. T. Saito is a visiting fellow from Kitasato University, Japan.

Accepted for publication May 23, 1983.




This article has been cited by other articles:


Home page
NeurologyHome page
M. Eurelings, K.G.M. Moons, N.C. Notermans, L.D. Sasker, A.E.J. De Jager, A.R. Wintzen, J.H.J. Wokke, and L.H. Van den Berg
Neuropathy and IgM M-proteins: Prognostic value of antibodies to MAG, SGPG, and sulfatide
Neurology, January 23, 2001; 56(2): 228 - 233.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. S. Katz, D. S. Saperstein, G. Gronseth, A. A. Amato, and R. J. Barohn
Distal acquired demyelinating symmetric neuropathy
Neurology, February 8, 2000; 54(3): 615 - 615.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. C. Gominak and D. P. Cros
Case 13-1998- A 23-Year-Old Man with Progressive Weakness and Paresthesias
N. Engl. J. Med., April 23, 1998; 338(17): 1212 - 1219.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by AAN Enterprises, Inc.